Evolution of CLL treatment — from chemoimmunotherapy to targeted and individualized therapy
Evolution of CLL treatment — from chemoimmunotherapy to targeted and individualized therapyEvolution of CLL treatment — from chemoimmunotherapy to targeted and individualized therapy, Published online: 18 May 2018; doi:10.1038/s41571-018-0037-8In recent years, a number of novel agents have been added to the therapeutic armamentarium for patients with chronic lymphocytic leukaemia (CLL). Herein, Jan A. Burger and Susan O’Brien outline the emerging paradigm of individualized therapy for patients with CLL aimed at exploiting the advantages of these novel agents but also integrating traditional therapies for selected patients.
Source: Nature Clinical Practice Oncology - Category: Cancer & Oncology Authors: Jan A. Burger Susan O ’Brien Source Type: research